Company Overview of ZetaRx Biosciences, Inc.
ZetaRx Biosciences, Inc., a biotechnology company, develops therapies using genetically engineered lymphocites for the treatment of cancers and other diseases. The company was formerly known as ZetaRX LLC. ZetaRx Biosciences, Inc. was founded in 2008 and is based in Seattle, Washington. As of September 30, 2013, ZetaRx Biosciences, Inc. operates as a subsidiary of Juno Therapeutics Inc.
307 Westlake Avenue North
Seattle, WA 98109
Founded in 2008
Key Executives for ZetaRx Biosciences, Inc.
ZetaRx Biosciences, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact ZetaRx Biosciences, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.